Related Experiment Video
Updated: Sep 21, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort,
Adam Abdullahi1,2,3, Edun Martin3, Asare Kwabena4
1Takemi Program in International Health, Harvard Chan School of Public Health, Boston, Massachusetts, USA.
Abstract:
In a retrospective Nigerian cohort of 33 982 people with HIV-1 initiating or switching to tenofovir, lamivudine, and dolutegravir, virological suppression reached 80%-82% among participants with available viral load data and 63%-65% by intention-to-treat analysis. Suppression was higher among switchers, while age and gender predicted suppression.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
Longitudinal Research
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Subviral Agents
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

